Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Oktober 2016 09:00 ET | Quelle: Activx Biosciences, Inc.

ActivX Biosciences Publishes Two Key Articles Demonstrating Breadth of Applications for KiNativ(R) Technology in Drug Discovery

LA JOLLA, CA--(Marketwired - Oct 20, 2016) - ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile,...
06. Juli 2011 06:00 ET | Quelle: Activx Biosciences, Inc.

Going KiNativ(TM): ActivX Publishes Landmark Article on Kinase Profiling

LA JOLLA, CA--(Marketwire - Jul 6, 2011) - ActivX Biosciences, Inc. announced today the publication of "In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases" in the...
04. Januar 2010 09:00 ET | Quelle: Activx Biosciences, Inc.

Activx Biosciences Head Receives Distinguished Scientist Award

LA JOLLA, CA--(Marketwire - January 4, 2010) - Dr. John W. Kozarich, Chairman & President of Activx Biosciences, Inc. (La Jolla, CA), has received the 2009 Distinguished Scientist Award from the...
21. August 2008 06:00 ET | Quelle: Activx Biosciences, Inc.

Activx Biosciences, Inc. Announces Positive Phase Ib and IIa Clinical Trial Results for KRP-104, a Flexible Dosing DPP-4 Inhibitor for Type 2 Diabetes

LA JOLLA, CA--(Marketwire - August 21, 2008) - Activx Biosciences, Inc., a wholly owned subsidiary of Tokyo-based Kyorin Pharmaceutical Co., Ltd., announced today topline results from their Phase Ib...